Slide background
Mersin Üniversitesi

  Professor Seyhan Şahan Fırat
users.ozgecmis
:
Department
:
Faculty of Pharmacy .
BIRTH DATE
:
12 June 1976 .
Business Address
:
Mersin Üniversitesi Eczacılık Fakültesi Yenişehir Kampüsü 33120 Yenişehir/ Mersin .
Mobile Phone
:
+90-555-2769733 .
Phone
:
+90-324-3412815 .
Internal
:
2613 .
Fax
:
+90-- .
Alternative e-mail
:
Alternative e-mail
:
Created
:
2015-06-26 11:57:00 .
Last Modification
:
2019-04-08 10:45:35 .
TOTAL ARTICLES IN
PUBLICATIONS LIST
0
ARTICLES WITH
CITATION DATA
0
SUM OF THE
TIMES CITED
0
AVERAGE CITATIONS
PER ARTICLE
0
Researcher ID
Scholar ID
h-index
11
Point

Degree Department/Program Institute Year
FACULTY OF VETERINARY MEDICINE ANKARA UNIVERSITY 1999
PHD PHARMACOLOGY AND TOXICOLOGY ANKARA UNIVERSITY HEALTH SCIENCE INSTITUTE 2005
Doctorate Thesis

1. Hidrate Sodyum Kalsiyum Aluminosilikatle Beslenen Etlik Piliçlerde Enrofloksasinin Farmakokinetiği , Supervisor: Dr. Prof. Dr. Sezai KAYA, Ankara University, Graduate School of Health Sciences, Pharmacology-Toxicology Department, Ankara, Turkey, .

Title Institute Year
ASSISTANT PROFFESSOR MERSIN UNIVERSITY 2006-08-28 - 2013-05-07
ASSOCIATE PROFFESSOR MERSIN UNIVERSITY 2013-05-07 - 2018-08-01
PROF. DR. MERSIN UNIVERSITY 2018-08-01 - Continue
Title Dutie Institution/Other Year
ANABILIM DALI BASKANI ANA BILIM DALI BASKANLIGI MERSIN UNIVERSITESI ECZACILIK FAKULTESI FARMAKOLOJI ABD 2018-12-26 - 2021-12-26
KOMISYON UYESI EMEKLILIK YAS HADDINI DOLDURMUS OGRETIM UYELERININ SOZLESMELI OLARAK CALISMASINI DEGR. KOMISYONU MERSIN UNIVERSITESI 2018-04-18 - 2018-07-26
MERSIN UNIVERSITESI ECZACILIK FAKULTESI YONETIM KURULU UYELIGI MERSIN UNIVERSITESI ECZACILIK FAKULTESI YONETIM KURULU UYELIGI MERSIN UNIVERSITESI ECZACILIK FAKULTESI 2017-02-21 - 2018-08-03
ASSOC. PROF. EDUCATION COMMITTEE MEMBERSHIP MERSIN UNIVERSITY FACULTY OF PHARMACY 2015-02-13 - 2018-07-08
ASSOC. PROF. FACULTY COMMITTEE MEMBERSHIP MERSIN UNIVERSITY FACULTY OF PHARMACY 2013-10-21 - 2016-10-21
International - SCI/SCI-Expanded category 13000
2018
29. şahan fırat, S. . CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, , -. 1000 + 0
28. Tunçtan, B.; Küçükkavruk, .; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S. . INFLAMMATION, 2018, , -. 400 + 0
27. Unsal, D.; Kacan, M.; Temiz-resitoglu, M.; Guden, D.; Korkmaz, B.; Sari, A.; Buharalioglu, C.; Yildirim-yaroglu, H.; Tamer-gumus, L.; şahan fırat, S. The role of Syk/IĸB-α/NF-ĸB pathway activation in the reversal effect of BAY 61-3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan-induced non-septic shock. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. , 2018, 45, 155-165. 100 + 0
http://dx.doi.org/10.1111/1440-1681.12864

26. şahan fırat, S.; Temiz-resitoglu, M.; Guden, D.; Kucukkavruk, S.; Tunctan, B.; Sari, A.; Kocak, Z.; Malik, K. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway. INFLAMMATION, 2018, 41, 276-298. 750 + 0
http://dx.doi.org/10.1007/s10753-017-0686-2

25. şahan fırat, S.; Temiz reşitoğlu, M.; Güden, D.; Küçükkavruk, .; Tunçtan, B.; Sarı, A.; Zumrut, K.; Malik, K. . INFLAMMATION, 2018, , -. 750 + 0
24. şahan fırat, S. . CLIN EXP PHARMACOL PHYSIOL, 2018, , -. 1000 + 0
23. Tunctan, B.; Kucukkavruk, S.; Temiz-resitoglu, M.; Guden, D.; Sari, A.; şahan fırat, S. Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock. INFLAMMATION, 2018, 41, 337-355. 400 + 0
http://dx.doi.org/10.1007/s10753-017-0691-5

2017
22. Tunçtan, B.; Kucukkavruk, .; Temiz-reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S.; Paudyal, M.; Falck, J.; Malik, K. Inhibition of NLRP3 Inflammasome Contributes to Protective Effect of 5,14-HEDGE against Lipopolysaccharide-Induced Septic Shock. . INTERNATIONAL JOURNAL OF PHARMACOLOGY. , 2017, 40 , 366-386. 200 + 0
21. Temiz-resitoglu, M.; Kucukkavruk, S.; Guden, D.; Cecen, P.; Sari, A.; Tunctan, B.; Gorur, A.; Tamer-gumus, L.; Buharalioglu, C.; şahan fırat, S. Activation of mTOR/IκB-α/NF-κB pathway contributes to LPS-induced hypotension and inflammation in rats. EUROPEAN JOURNAL OF PHARMACOLOGY , 2017, 802, 7-19. 100 + 15
http://dx.doi.org/10.1016/j.ejphar.2017.02.034


Times Cited: 3
20. Dolunay, A.; Senol, S.; Temiz-resitoglu, M.; Guden, D.; Sari, A.; şahan fırat, S.; Tunctan, B. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms. INFLAMMATION, 2017, 40, 366-386. 300 + 5
http://dx.doi.org/10.1007/s10753-016-0483-3


Times Cited: 1
2016
19. şenol, .; Reşitoğlu, M.; Güden, D.; çeçen, P.; Sarı, A.; şahan fırat, S.; Falck, J.; Dakarapu, R.; Malik, K.; Tunçtan, B. Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock. . INFLAMMATION RESEARCH, 2016, 65, 367-387. 150 + 10

Times Cited: 2
2014
18. Sari, A.; Kacan, M.; Unsal, D.; şahan fırat, S.; Buharalioglu, C.; Vezir, O.; Korkmaz, B.; Cuez, T.; Canacankatan, N.; Sucu, N. Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723, 234-245. 350 + 55
https://dx.doi.org/10.1016/j.ejphar.2013.11.027


Times Cited: 11
17. Urhan kucuk, M.; Sucu, N.; şahan fırat, S.; Aytacoglu, B.; Vezir, O.; Bozali, C.; Canacankatan, N.; Kul, S.; Tunctan, B. Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts.. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70, 1443-51. 500 + 40
https://dx.doi.org/10.1007/s00228-014-1751-5


Times Cited: 8
16. Sari, A.; Korkmaz, B.; Serin, M.; Kacan, M.; Unsal, D.; Buharalioglu, C.; şahan fırat, S.; Manthati, V.; Falck, J.; Malik, K. Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKK beta/I kappa B-alpha/NF-kappa B pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. INFLAMMATION RESEARCH, 2014, 63, 741-756. 100 + 18
https://dx.doi.org/10.1007/s00011-014-0747-z


Times Cited: 3
2013
15. Tunctan, B.; Sari, A.; Kacan, M.; Unsal, D.; Buharalioglu, C.; şahan fırat, S.; Korkmaz, B.; Falck, J.; Malik, K. NS-398 reverses hypotension in endotoxemic rats: Contribution of eicosanoids, NO, and peroxynitrite. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 104, 93-108. 200 + 0
https://dx.doi.org/10.1016/j.prostaglandins.2012.08.007

14. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; şahan fırat, S.; Cuez, T.; Schunck, W. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2013, 33, 18-41. 100 + 20
https://dx.doi.org/10.1016/j.niox.2013.05.001


Times Cited: 4
13. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; şahan fırat, S.; Cuez, T.; Schunck, W. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: Contribution of soluble epoxide:hydrolase, CYP2C23, MEK1/ERK1/2/IKK beta/IKB-alpha./NF-kappa B pathway, and proinflammatory. . PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 102, 31-41. 100 + 10
https://dx.doi.org/10.1016/j.prostaglandins.2013.01.005


Times Cited: 2
2012
12. Canacankatan, N.; Sucu, N.; Aytacoglu, B.; Gul, O.; Gorur, A.; Korkmaz, B.; şahan fırat, S.; Antmen, E.; Tamer, L.; Ayaz, L. Affirmative Effects of Iloprost on Apoptosis during Ischemia-Reperfusion Injury in Kidney as a Distant Organ. RENAL FAILURE, 2012, 34, 111-118. 100 + 30
https://dx.doi.org/10.3109/0886022X.2011.633446


Times Cited: 6
11. Malik, K.; Jennings, B.; Yaghini, F.; şahan fırat, S.; Song, C.; Estes, A.; Fang, X. Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: A novel target for antihypertensive agents. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2012, 98, 69-74. 500 + 15
https://dx.doi.org/10.1016/j.prostaglandins.2011.12.003


Times Cited: 3
2011
10. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; şahan fırat, S.; Sari, A.; Malik, K.; Tunctan, B. Piroxicam Reverses Endotoxin-Induced Hypotension in Rats: Contribution of Vasoactive Eicosanoids and Nitric Oxide. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109, 186-194. 500 + 25

Times Cited: 5
9. Korkmaz, B.; Buharalioglu, K.; şahan fırat, S.; Cuez, T.; Tunçtan, B. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 24, 160-172. 700 + 50
https://dx.doi.org/10.1016/j.niox.2011.02.004


Times Cited: 10
2010
8. Cuez, T.; Korkmaz, B.; Buharalioglu, C.; şahan fırat, S.; Falck, J.; Malik, K.; Tunctan, B. A Synthetic Analogue of 20-HETE, 5,14-HEDGE, Reverses Endotoxin-Induced Hypotension via Increased 20-HETE Levels Associated with Decreased iNOS Protein Expression and Vasodilator Prostanoid Production in Rats. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106, 378-388. 500 + 55
https://dx.doi.org/10.1111/j.1742-7843.2009.00501.x


Times Cited: 11
7. Tunctan, B.; Korkmaz, B.; Cuez, T.; Buharalioglu, C.; şahan fırat, S.; Falck, J.; Malik, K. Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107, 877-882. 400 + 30
https://dx.doi.org/10.1111/j.1742-7843.2010.00589.x


Times Cited: 6
6. şahan fırat, S.; Jennings, B.; Yaghini, F.; Song, C.; Estes, A.; Fang, X.; Farjana, N.; Khan, A.; Malik, K. 2,3 ',4,5 '-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299, 1891-1901. 700 + 60
https://dx.doi.org/10.1152/ajpheart.00655.2010


Times Cited: 12
5. Jennings, B.; şahan fırat, S.; Estes, A.; Das, K.; Farjana, N.; Fang, X.; Gonzalez, F.; Malik, K. Cytochrome P450 1B1 Contributes to Angiotensin II-Induced Hypertension and Associated Pathophysiology. HYPERTENSION, 2010, 56, 667-667. 650 + 105
https://dx.doi.org/10.1161/HYPERTENSIONAHA.110.154518


Times Cited: 21
2008
4. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; şahan fırat, S.; Anjaiah, S.; Falck, J.; Roman, R.; Malik, K. A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. SHOCK, 2008, 30, 329-335. 450 + 95
https://dx.doi.org/10.1097/SHK.0b013e31816471c6


Times Cited: 19
2006
3. Buyukafsar, K.; Akca, T.; Tiffik, R.; şahan fırat, S.; Aydin, S. Contribution of Rho-kinase in human gallbladder contractions. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 540, 162-167. 600 + 45
https://dx.doi.org/10.1016/j.ejphar.2006.04.028


Times Cited: 9
2. Buyukafsar, K.; Yalcin, I.; Kurt, A.; Tiftik, R.; şahan fırat, S.; Aksu, F. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 541, 49-52. 450 + 110
https://dx.doi.org/10.1016/j.ejphar.2006.04.042


Times Cited: 22
2005
1. şahan fırat, S.; Tiftik, R.; Nacak, M.; Buyukafsar, K. Rho kinase expression and its central role in ovine gallbladder contractions elicited by a variety of excitatory stimuli. EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 528, 169-175. 950 + 35
https://dx.doi.org/10.1016/j.ejphar.2005.10.055


Times Cited: 7
International - Covered by Other International Indexes 230
2012
3. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; şahan fırat, S.; Schunck, W.; Falck, J. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 121-50. 20 + 25
2. Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Demiryurek, A.; şahan fırat, S.; Sari, A.; Tunctan, B. Contribution of MEK1/ERK1/2/iNOS pathway to oxidative stress and decreased caspase-3 activity in endotoxemic rats.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 243-52. 80 + 0
1. şahan fırat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A.; Kacan, M.; Unsal, D.; Tunctan, B. Increased production of nitric oxide mediates selective organ-specific effects of endotoxin on oxidative stress.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 161-72. 130 + 0
National - Covered by ULAKBIM 1120
2017
7. Urhan küçük, M.; Karaca, K.; şahan fırat, S.; Vezir, .; Canacankatan, N.; Aytaçoğlu, N.; Erden, S.; Tunçtan, B.; Sucu, N. Role of cytokine gene polymorphisms on ramipril-altered inflammatory response and myocardial injury in patients undergoing coronary artery bypass surgery. CUKUROVA MEDICAL JOURNAL, 2017, 42, 436-445. 100 + 0
2016
6. Temiz resitoglu, M.; Guden, D.; Sahan firat, S. Hipertansiyon Araştırmalarında Kullanılan Deneysel Modeller (Experimental Models Used in Hypertension Research). CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2016, 6, 35-43. 200 + 0
http://dx.doi.org/10.5152/clinexphealthsci.2016.052

2015
5. Güden, D.; Temiz, M.; Tunçtan, B.; şahan fırat, S. The role of endothelin-1 and new therapeutic approaches in sepsis and septic shock. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2015, 3, 178-190. 130 + 0
2014
4. ünsal, D.; Temiz, M.; Tunçtan, B.; şahan fırat, S. Signal transduction of zymosan and spleen tyrosine kinase. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2014, 3, 148-157. 130 + 0
2010
3. Sarı, A.; şahan fırat, S.; Tunçtan, B. Rho Kinase and Cardiovascular Diseases. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2010, 3, 1-7. 200 + 0
2008
2. şahan fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Sarı, A.; Tunctan, B. The Effect of Inducible Nitric Oxide Synthase Inhibition on Increased Oxidative Stress in the Liver of Endotoxemic Rats. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , 2008, 3, 28-35. 160 + 0
2006
1. şahan, S.; Kaya, S. Thepharmacokinetics of enrofloxacin in broiler chickens fed with containing hydrate sodium calcium aluminosilicate. ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI, 2006, 53, 111-115. 200 + 0
National - Other 400
2007
4. şahan, S.; Kaya, S. Sennae. VETERINER HEKIMLER DERNEGI DERGISI , 2007, 78, 35-38. 100 + 0
2005
3. şahan fırat, S.; Kaya, S. The Effect of Hydrated Sodium Calcium Aluminosilicate on Pharmacokinetics of Enrofloksasin Given İntracrop in Broiler Chickens. ULUDAG UNIVERSITESI VETERINER FAKULTESI DERGISI , 2005, 24, 59-63. 100 + 0
2. Kaya, S.; Eşsiz, D.; şahan, S. Acrylonitrile Poisoning. TURK VETERINER HEKIMLERI BIRLIGI DERGISI , 2005, 4, 61-66. 100 + 0
2004
1. Kaya, S.; şahan, S. Life with herbs 3: Nettle. TURK VETERINER HEKIMLERI BIRLIGI DERGISI , 2004, 4, 43-46. 100 + 0
International - Abstract - Oral 365

8. Güden, D.; Temiz-Resitoglu, M.; Küçükkavruk, Ş.; Tunçtan, B.; Şahan Fırat, S., Protective effect of mTOR inhibition on lps-induced systemic inflammation and tissue injury: contribution of mTOR/IκB-α/NF-κB/HIF-1α signaling pathway and NADPH oxidase system activity. . 12th International Symposium on Pharmaceutical Sciences (ISOPS-12), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 50

7. Şahan Fırat, S.; KOÇAK, Z.; TEMİZ REŞİTOĞLU, M.; Güden, D.; Vezir, Ö.; Sucu, N.; Balcı, Ş., Role of mTOR/IκB-α/NF-κB pathway activation in ischemia/reperfusion-induced inflammatory response in rats.. Pharmacology 2017, 2017-12-11, 2017-12-13, Londra, England / United Kingdom, 2017. 75

6. Tunctan, B.; Kucukkavruk, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Şahan Fırat, S.; P, P., Contribution of NLRP3 inflammasome to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against LPS-induced septic shock in rats.. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Armsterdam, Netherlands, 2017. 20

5. Tunctan, B.; Kucukkavruk, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Şahan Fırat, S., Protective effects of Bexarotene, a selective RXR agonist, reverses hypotension associated with inflammation and tissue injury via decreased Circulating iNOS levels in a rat model of septic shock.. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Armsterdam, Netherlands, 2017. 40

4. Tunctan, B.; Dolunay, A.; Şenol, Ş.; Reşitoğlu, M.; Güden, D.; Sarı, A.; Şahan Fırat, S., Inhibition of NLRP3 Inflammasome prevents lipopolisaccharide-induced inflammatory hyperalgesia in mice: contribution of NF-κB, caspase-1/11, ASC, NADPH oxidase, and NOS isoforoms. . 7th European Congress of Pharmacology (EPHAR 2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 20

3. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C., Contribution of iNOS, COX-2 and CYP4A1 to the protective effect of a synthetic analog of 20-HETE, 5,14-HEDGE, against endotoxin-induced hypotension and mortality in experimental model of septic shock in rats and mice. . 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, Turkey, 2011. 10

2. Jennings, B.; Das, K.; Şahan Fırat, S.; Estes, A.; Malik, K., Contribution of Cytochrome P450 1B1 to Angiotensin II-induced Hypertension. . 63rd High Blood Pressure Research Conference 2009, 2009-09-23, 2009-09-26, Chicago, United States of America, 2009. 70

1. Tunçtan, B.; Korkmaz, B.; Cüez, T.; Buharalıoğlu, C.; Şahan Fırat, S.; Falck, J.; Malik, K., Interactions between Cytochrome P450A, Cyclooxygenase and Nitric Oxide Synthase during Endotoxemia: Therapeutic Implications for İnflammatory Diseases. . EHRLICH II, 2nd World Conference on Magic Bullets, 2008-10-03, 2008-10-05, Nurnberg, Germany, 2008. 40

International - Abstract - Poster 1105

33. Küçükkavruk, Ş.; Temiz-Resitoglu, M.; Guden, D.; Sarı, A.; Şahan Fırat, S.; Tunçtan, B., Bexarotene, a RXRα agonist, prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice. . 12th International Symposium on Pharmaceutical Sciences (ISOPS-12), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 22

32. Pire, Z.; Güden, D.; Şahan Fırat, S., Treatment approaches focused on apoptosıs ın cancer. . 2nd International Congress on Multidisciplinary Studies (II. Uluslararası Multidisipliner Çalışmaları Kongresi), 2018-05-04, 2018-05-05, Adana, Turkey, 2018. 50

31. Akıncı Uysal, Ç.; Temiz-Resitoglu, M.; Şahan Fırat, S., Role of Autophagy in the treatment of Neurodegenerative Diseases.. 2nd International Congress on Multidisciplinary Studies (II. Uluslararası Multidisipliner Çalışmaları Kongresi), 2018-05-04, 2018-05-05, Adana, Turkey, 2018. 50

30. ŞAHAN FIRAT, S., mTOR Pathway at a Glance: Modulation of Autophagy. . International Eurasian Conferences on Biological and Chemical Sciences, 2018-04-26, 2018-04-27, Ankara, Turkey, 2018. 50

29. Temiz-Resitoğlu, M.; Şahan Fırat, S., The mTOR Signaling in the Cardiovascular System. . International Eurasian Conferences on Biological and Chemical Sciences, 2018-04-26, 2018-04-27, Ankara, Turkey, 2018. 50

28. Güden, D.; Şahan Fırat, S., Experimental Models in Alzheimer’s Disease.. International Eurasian Conferences on Biological and Chemical Sciences, 2018-04-26, 2018-04-27, Ankara, Turkey, 2018. 50

27. Güden, D.; KOÇAK, Z.; Temiz-Resitoglu, M.; vezir, o.; sucu, n.; balcı, ş.; tamer-gümüş, l., Contribution of mTOR to oxidative/nitrosative stress leading to organ injury in a rat model of hindlimb ischemia/reperfusion. . Pharmacology 2017, 2017-12-11, 2017-12-13, Londra, England / United Kingdom, 2017. 5

26. ŞAHAN FIRAT, S.; Temiz-Resitoglu, M.; Guden, D.; Kucukkavruk, Ş.; Tunctan, B.; Sari, A.; Kocak, Z., Activation of mTOR/MEK1/ERK1/2/IKKβ/IκB-α//NF-ĸB p65 Pathway Contributes to Zymosan-Induced Systemic Inflammatory Response in Rats. . 2nd International Gazi Pharma Symposium Series (GPSS-2017), 2017-10-11, 2017-12-13, Ankara, Turkey, 2017. 40

25. Tunçtan, B.; Küçükkavruk, Ş.; TEMİZ REŞİTOĞLU, M.; Guden, D.; Sari, A.; Şahan Fırat, S., Bexarotene, a selective RXRa agonist, reverses hypotension associated with inflammation and tissue injury via increased formation of PPARa/b/g-RXRa heterodimers in a rat model of septic shock. . . 17th Congress of European Shock Society: numerous "premières" , 2017-09-13, 2017-09-15, Paris, France, 2017. 20

24. Güden, D.; Şahan Fırat, S., Evaluation of gut-brain axis theory in depression: the light and blind side.. VI. International Congress of Molecular Medicine, 2017-05-22, 2017-05-25, İstanbul, Turkey, 2017. 50
http://www.moltipder.org/Kongre2017_En.html

23. Şahan Fırat, S.; Temiz-Resitoglu, M.; Guden, D.; Kucukkavruk, S.; Tunctan, B.; Sari, A.; Kocak, Z., Contribution of mTOR to oxidative/nitrosative stress via NADPH oxidase system activation in zymosan-induced systemic inflammation in rats. . ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Armsterdam, Netherlands, 2017. 40

22. Temiz-Resitoğlu, M.; Şahan Fırat, S., Novel therapeutic approaches in the treatment of hypertension. . IVEK 3rd International Convention of Phatmaceuticals and Pharmacies, 2017-04-26, 2017-04-29, İstanbul, Turkey, 2017. 50

21. Şahan Fırat, S., mTOR inhibition: a promising target for cancer therapy. . IVEK 3rd International Convention of Phatmaceuticals and Pharmacies, 2017-04-26, 2017-04-29, İstanbul, Turkey, 2017. 50

20. Akıncı-Uysal, Ç.; Şahan Fırat, S., Parkinson Hastalığı'nın Tedavisinde Müzik. . IVEK 3rd International convention of pharmaceuticals and Pharmacies, 2017-04-26, 2017-04-29, Mersin, Turkey, 2017. 50

19. Guden, D.; Şahan Fırat, S., The role of pharmacist interventions in the rational use of antidepressants. . IVEK 3rd International convention of pharmaceuticals and Pharmacies, 2017-04-26, 2017-04-29, İstanbul, Turkey, 2017. 50

18. Şahan Fırat, S.; Temiz Reşitoğlu, M.; Buharalıoğlu, C.; Güden, D.; Şenol, Ş.; Sarı, A.; Kaçan, M., The Role of IkB-a/NF-KB Pathway Activation in Hypotension and Inflammation Reversed by BAY 61-3606, A Selective Syk Inhibitor, in Rat Models of Septic and Non-Septic Shock. . 7th European Congress of Pharmacology (EPHAR 2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 32

17. Canacankatan, N.; Yilmaz, N.; Sucu, N.; Gul, O.; Gorur, A.; Aytacoglu, B.; Korkmaz, B., Effect of Iloprost, a prostacyclin derivative on apoptosis during ischemia-reperfusion injury in lung as a distant organ. . 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 5

16. Temiz, M.; Şenol, Ş.; Guden, D.; Cecen, P.; Sari, A.; Tunctan, B.; Gorur, A., Inhibition of Mammalian Target of Rapamycin Reverses Lipopolysaccharide-Induced Hypotension and Inflammation in Rats. . 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 5

15. Canacankatan, N.; Sucu, N.; Gul, O.; Gorur, A.; Aytacoglu, B.; Korkmaz, B.; Şahan Fırat, S., Iloprost, a prostacyclin analogue prevents limb ischemia-reperfusion injury by reducing apoptosis in rats. . 10thInternational Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 5

14. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C., A synthetic analog of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension and mortality via increased expression and activities of CYP4A1 and CYP2C23 in a rodent model of septic shock: contribution of MEK1/ERK1/2/IKKb/IkB-a/NF-kB pathway and soluble epoxide hydrolase. The 1st Central and Eastern European Conference on Sepsis, 2012-03-17, 2012-03-20, Budapeşte, Hungary, 2012. 5

13. Tunctan, B.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C.; Şahan Fırat, S.; Korkmaz, B., NS-398, a selective COX-2 inhibitor, reverses endotoxin-induced hypotension via increased CYP4A1 expression and 20-HETE levels associated with decreased COX-2 and iNOS expression and/or activity in a rat model of septic shock.. The 14th International Winter Eicosanoid Conference, 2012-03-11, 2012-03-14, Baltimore, United States of America, 2012. 10

12. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Şahan Fırat, S.; sari, A.; Malik, K.; Tunctan, B., A selective cyclooxygenase-1 inhibitor, piroxicam, reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide. . 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 25

11. Canacankatan, N.; Sucu, N.; Şahan Fırat, S.; Gorur, A.; Antmen, E.; Korkmaz, B.; Tunctan, B., Attenuation of Ischemia-Reperfusion Injury by Iloprost on Apoptosis and Antioxidant Capacity in Kidney as a Distant Organ.. 3rd International Congress on Cell Membranbes and Oxidative Stress: Focus on Calcium Signalling and TRP Channels, 2010-06-22, 2010-06-27, Isparta, Turkey, 2010. 22

10. Jennings, B.; Şahan Fırat, S.; Estes, A.; Malik, K., Contribution of Cytochrome (CYP) P450 1B1 in Various Models of Hypertension in Rats and Mice: A Novel Target for the Development of Anti-Hypertensive Agents. . Experimental Biology 2010, 2010-04-24, 2010-04-28, Anaheim, Turkey, 2010. 42

9. Şahan Fırat, S.; Jennings, B.; Estes, A.; Farjana, N.; Khan, A.; Fang, X.; Malik, K., DOCA/Salt-induced hypertension and associated increase in vascular reactivity and cardiac and vascular hypertrophy are mediated by cytochrome P450 1B1. . Experimental Biology 2010, 2010-04-24, 2010-04-28, Anaheim, United States of America, 2010. 40

8. Tunctan, B.; Korkmaz, B.; Cuez, T.; Şahan Fırat, S.; Yildirim, H.; Tamer, L.; Buharalioglu, C., Increased production of 20-HETE contributes to the effects of COX inhibitors to prevent the decrease in lipid peroxidation and increase in catalase activity during endotoxemia. . Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, Turkey, 2009. 20

7. Şahan Fırat, S.; Korkmaz, B.; Cüez, T.; Ayaz, L.; Tamer, L.; Buharalıoğlu, C.; Sarı, A., Prostaglandins contribute to endotoxin-induced increase in lipid peroxidation via nitric oxide production during endotoxemia in rats. . Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 37

6. Buharalioglu, C.; Ozbasoglu, O.; Korkmaz, B.; Cuez, T.; Şahan Fırat, S.; Yalcin, A.; Tunctan, B., Thalidomide potentiates analgesic effect of COX inhibitors on endotoxin-induced hyperalgesia by modulating TNF-a, PGE and NO synthesis in mice. . Experimental Biology 2009, 2009-04-18, 2009-04-22, New orleans, Turkey, 2009. 20

5. Korkmaz, B.; Buharalioglu, C.; Demiryurek, T.; Şahan Fırat, S.; Cuez, T.; Tunctan, B., Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway contributes to the fall in blood pressure and vascular reactivity in endotoxemic rats. . Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, Turkey, 2009. 27

4. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Şahan Fırat, S.; Anjaiah, S.; Falck, J.; Yildirim, H., 20-HETE agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the endotoxin-induced fall in blood pressure and the decrease in vascular reactivity and lipid peroxidation and increased catalase activity via inhibition of NO production in rats. . Experimental Biology 2008, 2008-04-05, 2008-04-09, San diego, Turkey, 2008. 5

3. Şahan Fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Buharalioglu, C.; Sari, A., Differential regulation of oxidative stress by NO in vascular and nonvascular tissues of endotoxemic rats.. Experimental Biology 2008, 2008-04-05, 2008-04-09, San diego, Turkey, 2008. 37

2. Şahan Fırat, S.; Kaya, S., The Pharmacokinetics of Enrofloxacin in broiler chickens fed with feed containing hydrate sodium calcium aluminosilicate. . Birinci Ulusal Veteriner Farmakoloji ve Toksikoloji Kongresi (Uluslararası katılımlı), 2005-09-22, 2005-09-24, Ankara, Turkey, 2005. 50

1. Şahan Fırat, S.; Tiftik, R.; Nacak, M.; Büyükafşar, K., Central role of Rho/Rho-kinase pathway in the neurogenic contractile activity of the sheep gallbladder smooth muscle. . 4th National Congress of Neuroscience, 2005-03-29, 2005-04-02, Mersin, Turkey, 2005. 47

National - bilimsel-toplantilar.icerikTurleri. - Poster 0

4. kılıç, b.; GÜDEN, D.; ŞAHAN FIRAT, S., Akciğer kanserinde hedefe yönelik tedavi: Monoklonal antikorlar.. 2. Ulusal Marmara Eczacılık Kongresi, 2018-11-14, 2018-11-16, , Turkey, . 0

3. paşa, s.; TEMİZ REŞİTOĞLU, M.; ŞAHAN FIRAT, S., Romatoit artrit tedavisinde güncel yaklaşımlar.. 2. Ulusal Marmara Eczacılık Kongresi, 2018-11-14, 2018-11-16, , Turkey, . 0

2. yıldız, m.; TEMİZ REŞİTOĞLU, M.; ŞAHAN FIRAT, S., Çocuklarda depresyon ve tedavi yaklaşımları.. . 2. Ulusal Marmara Eczacılık Kongresi, 2018-11-14, 2018-11-16, , Turkey, . 0

1. bazzaz, i.; GÜDEN, D.; TEMİZ REŞİTOĞLU, M.; ŞAHAN FIRAT, S., Depresyon mediyatörleri: Sitokinler.. 2. Ulusal Marmara Eczacılık Kongresi, 2018-11-14, 2018-11-16, , Turkey, . 0

National - Full text - Oral 100

1. Şahan Fırat, S., Sistemik Inflamatuvar Yanıt Sendromu (SIRS). Türk Farmakoloji Derneği XXII. Eğitim Toplantısı - Doğu Akdeniz Farmakoloji Topluluğu (DAFT) İş Birliğiyle "İnflamasyon ve Ağrı", 2015-05-29, 2015-05-29, Adana, Turkey, 2015. 100

National - Abstract - Oral 202

12. Temiz, M.; Şenol, Ş.; Güden, D.; , P.; Sarı, A.; Tunçtan, B.; Görür, A., Endotoksemik sıçanlarda ortaya çıkan sistemik inflamatuvar yanıtta mTOR/IκB-/NF-κB yolu etkinliğinin rolü. . 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 5

11. Şenol, Ş.; Temiz, M.; Güden, D.; Çeçen, P.; Sarı, A.; Şahan Fırat, S.; Falck, J., Sıçanlarda oluşturulan deneysel septik şok modelinde 20- HETE mimetik 5,14-HEDGE’nin hipotansiyon, taşikardi ve enflamasyona karşı koruyucu etkisine PPAR/β/γ, AP-1, importin-3 ve RXR’nın katkısı. . 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 7

10. Kacan, M.; Unsal, D.; Temiz, M.; Korkmaz, B.; Sari, A.; Şahan Fırat, S.; Yıldırım Yaroğlu, H., Sıçanlarda lipopolisakkarit ile oluşan enflamasyon ve hipotansiyona dalak tirozin kinazının katkısının araştırılması.. 22. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 7

9. sari, A.; Korkmaz, B.; Serin, M.; Kacan, M.; Unsal, D.; Buharalıogğu, C.; Şahan Fırat, S., Sıçanlarda oluşturulan deneysel septik şok modelinde 20-HETE analoğu 5,14-HEDGE'nin yararlı etkilerine MyD88/TAK1/IKKβ/NF-B yolu etkinliği ile birlikte sistemik miR-150, miR-223 ve miR-297 ekspresyon düzeylerindeki azalmanın katkısı. . 22. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 5

8. Urhan Küçük, M.; Sucu, N.; Şahan Fırat, S.; Aytaçoğlu, B.; Vezir, Ö.; Bozali, C.; Canacankatan, N., Ramiprilin koroner arter by pass cerrahisi hastalarında inflamatuar yanıt ve miyokardiyal hasara etkisinde ACE I/D gen polimorfizminin rolü. . XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2013-10-27, 2013-10-30, Aydın, Turkey, 2013. 25

7. Tunçtan, B.; Korkmaz, B.; Cüez, T.; Sarı, A.; Kaçan, M.; Gilik, D.; Buharalıoğlu, C., Sıçan ve farelerde oluşturulan deneysel septik şok modelinde 20-HETE analoğu 5,14-HEDGE’nin hipotansiyonu ve mortaliteyi önleyici etkisine iNOS, COX-2, CYP4A1 ve NADPH oksidazın katkısı. . 21. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 5

6. Sarı, A.; Kacan, M.; Şahan Fırat, S.; Buharalıoğlu, C.; Vezir, Ö.; Korkmaz, B.; Cüze, T., Sıçanlarda oluşturulan Periferik İskemi/Reperfüzyona bağlı hedef organ gastroknemius kası ve uzak organ böbrek zedelenmesine RhoA/Rho-Kinaz/ERK1/2/iNOS/NADPH Oksidaz yolunun katkısı. . 21. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2008. 25

5. Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Demiryurek, T.; Şahan Fırat, S.; Tunctan, B., Endotoksemik sıçanlarda gelişen kaspaz-3 aracılıklı apoptoza ve oksidatif strese MEK1/ERK1/2/iNOS yolunun katkısı. 20. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 22

4. Tunctan, B.; Cuez, T.; Korkmaz, B.; Şahan Fırat, S.; Buharalioglu, C.; Yildirim, H.; Sari, A., Endotoksemik sıçanlarda NO oluşumundaki artmaya 20-HETE düzeylerindeki azalmanın eşlik ettiği oksidatif stres ve inflamasyon üzerinde yapay bir 20-HETE analoğu olan N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin etkisi. . 20. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 17

3. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Şahan Fırat, S.; Anjaiah, S.; Falck, J.; Roman, R., Endotoksin ile olusan nitrik oksit aracilikli hipotansiyon ve vaskuler hiporeaktivite üzerinde selektif 20-hidroksieikozatetraenoik asit agonisti N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin etkileri.. 19. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 22

2. Korkmaz, B.; Buharalioglu, C.; Demiryurek, A.; Şahan Fırat, S.; Tunctan, B., Endotoksemik sicanlarin torasik aortasinda gelisen vaskuler hiporeaktiviteye indüklenebilir nitrik oksit sentaz/çözunebilir guanilil siklaz/protein kinaz G yolunun katkisi.. 19. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 30

1. Buyukafsar, K.; Akca, T.; Tiftik, R.; Şahan Fırat, S.; Aydin, S., İnsan Safra Kesesinde Rho-kinaz Enzim Ekspresyonu ve Kontraktil Aktivitedeki Esaslı Rolü.. 18. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 30

National - Abstract - Poster 176

14. Tunctan, B.; Kucukkavruk, Ş.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Şahan Fırat, S., Sıçanlarda oluşturulan deneysel septik şok modelinde seçici bir RXR agonisti olan beksaroten enflamasyon ve doku zedelenmesi ile birlikte olan hipotansiyonu geri çevirmektedir.. 24. Ulusal Farmakoloji Kongresi 8. Klinik Farmakoloji Sempozyumu 7. Klinik Toksikoloji Sempozyumu. , 2017-11-17, 2017-11-21, Trabzon, Turkey, 2017. 10

13. Güden, D.; Şahan Fırat, S., Alzheimer hastalığınının patojenezinde yer alan inflamasyonun gelişmesinde bağırsak-beyin aksının önemli katkısı.. 24. Ulusal Farmakoloji Kongresi 8. Klinik Farmakoloji Sempozyumu 7. Klinik Toksikoloji Sempozyumu., 2017-11-17, 2017-11-21, Trabzon, Turkey, 2017. 25

12. TUNÇTAN, B.; KÜÇÜKKAVRUK, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S., Sıçanlarda oluşturulan deneysel septik şok modelinde seçici bir RXR agonisti olan beksaroten enflamasyon ve doku zedelenmesi ile birlikte olan hipotansiyonu geri çevirmektedir.. 24. Ulusal Farmakoloji Kongresi 8. Klinik Farmakoloji Sempozyumu 7. Klinik Toksikoloji Sempozyumu, 2017-10-17, 2017-10-21, , Turkey, . 10

11. Saltanlar, M.; Güden, D.; Şahan Fırat, S., Depresyon Tedavisinde Değişen Hedefler. . 1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu, 2017-06-01, 2017-06-02, Eskişehir, Turkey, 2017. 25

10. Değer, F.; Temiz-Resitoglu, M.; Şahan Fırat, S., Parkinson Hastalığının Tedavisinde Yeni Gelişmeler. . 1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu , 2017-06-01, 2017-06-02, Eskişehir, Turkey, 2017. 25

9. Tunçtan, B.; Şahin, N.; Utku, S.; Şahan Fırat, S.; Döğen, A.; Battal, D.; Ünal, Z., Ulusal Eczacılık Çekirdek Eğitim Programı ve Akreditasyon Süreci Çalışmalarının Mersin Üniversitesi Eczacılık Fakültesine Kazandırdıkları. . I. Ulusal Eczacilik Egitimi ve Akreditasyon Kongresi, 2016-05-09, 2016-05-10, Ankara, Turkey, 2016. 8

8. Ünsal, D.; Kaçan, M.; Temiz, M.; Güden, D.; Korkmaz, B.; Sarı, A.; Buharalıoğlu, C., Sıçanlarda Dtk/IκB-/NF-κB yolu etkinliğindeki artışın zimosanın neden olduğu inflamatuvar yanıta katkısı. . 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 2

7. Ordu, H.; Temiz, M.; Tunçtan, B.; Şahan Fırat, S., Sağlığın Sembolü: Gılgamış Destanı’ndan Asklepios’a Yılan. . XI. Türk Eczacılık Tarihi Toplantısı, 2014-05-25, 2014-05-28, Kayseri, Turkey, 2014. 16

6. Unsal, D.; Kaçan, M.; temiz, M.; Korkmaz, B.; Sarı, A.; Buharalıoğlu, C.; Yıldırım Yaroğlu, H., Sıçanlarda zimosanın neden olduğu enflamasyon ve hipotansiyona dalak tirozin kinazının katkısı. . 22. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 2

5. Görür, A.; Canacankatan, N.; Gül, O.; Algül, Ö.; Erdoğan, S.; Korkmaz, B.; Şahan Fırat, S., Hepatoselüler karsinom gelişim sürecinde bazı benzimidazol türevlerinin antioksidan kapasite üzerine etkisi.. XXIII. Ulusal Biyokimya Kongresi, 2011-11-29, 2011-12-02, Adana, Turkey, 2011. 2

4. Buharalıoğlu, C.; Sarı, A.; Kaçan, M.; Gilik, D.; Korkmaz, B.; Cüez, T.; Şahan Fırat, S., Endotoksemik sıçanlarda Piroksikamın hipotansiyonu önleyici etkisine MEK1/ERK1/2/iNOS/NADPH Oksidaz yolunun katkısı. . 21. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 2

3. Cuez, T.; Korkmaz, B.; Buharalıoğlu, C.; Şahan Fırat, S.; Falck, J.; Malik, K.; Tunctan, B., Endotoksemik sıçanlarda N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin eNOS, iNOS ve hsp90 protein ekspresyonu ile prostanoit ve 20-HETE düzeyleri üzerindeki etkisi. . 20. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 12

2. Sari, A.; Şahan Fırat, S.; Vezir, Ö.; Yılmaz, N.; Korkmaz, B.; Cüez, T.; Canacankatan, N., Seçici Rho-kinaz inhibitörü Y-27632'nin sıçanlarda oluşturulan periferik iskemi/reperfüzyona bağlı hedef organ gastroknemius kası ve uzak organ böbrek zedelenmesi üzerindeki etkisi. . 20. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 13

1. Şahan Fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Buharalıoğlu, C.; Tunctan, B., Endotoksemik Sıçanların Karaciğerinde Artan Oksidatif Stres Üzerinde İndüklenebilir Nitrik Oksit Sentaz İnhibisyonunun Etkisi.. 19. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 20

National - Manager 1100

11. Investigation of the effect of 20-HETE mimetic 5,14-HEDGE on GPR75/Gaq/11 signalling pathway in lipopolysaccharide-induced systemic inflammation model in rats, BAP, Project Number: 2019-1-AP3-3471, 23000 TL, Manager, Continue... 100

10. Investigation of the Contribution of mTOR Related to MEK1/ERK1/2 Activation in Inflammatory Response and Oxidative/Nitrossative Stress Processes Mediates to Peripheral Ischemia/Reperfusion Injury in Rats, BAP, Project Number: 2018-2-TP2-2984, 11000 TL, Manager, Continue... 100

9. Investigation of the Contribution of mTOR to Peripheral Ischemia/Reperfusion Injury Associated with Apoptosis in Rats, BAP, Project Number: 2018-1-TP2-2877, 11000 TL, Manager, Continue... 100

8. Investigation Of The Contribution Of Mtor To DOCA-Salt İnduced Hypertension And Associated Cardiovascular And Renal Pathophysiological Changes İn Rats, BAP, Project Number: 2018-1-TP3-2813, 21000 TL, Manager, Continue... 100

7. Sıçanlarda DOCA-tuz modeli ile oluşturulan deneysel hipertansiyon ve ilişkili kardiyovasküler ve renal patofizyolojik değişikliklerde mTOR'un katkısının araştırılması. , TÜBİTAK, Project Number: 118S168, 0 TL, Manager, Continue... 100

6. Investigation of the role of mTOR in lipopolysaccaride-induced systemic inflammatory response associated with neuroinflammation in rats , BAP, Project Number: 2017-1-TP3-1995, 21000 TL, Manager, 2017,Completed. 100

5. Investigation of the Role of mTOR in Systemic Inflammatory Response in Zymosan-Induced Non-Septic Shock Model in Rats, BAP, Project Number: 2016-2-AP3-1900, 14450 TL, Manager, 2017,Completed. 100

4. Investigation of the Contribution of mTOR to the Inflammation and Oxidative/Nitrossative Stress Develope in the Target and Distant Organ Injuries Due to Ischemia/Reperfusion in Rats, BAP, Project Number: 2016-2-TP2-1894, 11000 TL, Manager, 2016,Completed. 100

3. Investigation of mTOR to contribute via endotoxin induced hypotension in rats. , BAP, Project Number: BAP-SBE FB (MT) 2014-1 YL, 9918 TL, Manager, 2016,Completed. 100

2. Investigation of the effect of Dtk inhibition on NF-B signal transduction pathway in septic and nonseptic shock models. , BAP, Project Number: BAP-ECZ F EMBF (SŞF) , 46783 TL, Manager, 2015,Completed. 100

1. Investigation of the contribution of spleen tyrosine kinase to zymosan-induced hypotension in rats., BAP, Project Number: BAP-SBE (DG) 2011-5 YL, 10000 TL, Manager, 2013,Completed. 100

National - Researcher 1050

23. Investigation of role of Rho-Kinase in IL-1β -Induced Inflammation in human chondrocytes: contribution of IkB-α/NF-kB pathway , BAP, Project Number: 2017-2-AP3-2589, 20000 EUR, Researcher, 2018,Completed. 50

22. Lipopolisakkarit ile sıçanlarda olusturulan sistemik enflamasyon modelinde seçici RXRα agonisti beksarotenin iNOS ile CYP4F6 enzimlerinin ekspresyon ve etkinligi üzerindeki etkilerinin araştırılması, TÜBİTAK, Project Number: 215S679, 220000 TL, Researcher, 2018,Completed. 50

21. Investigation of the effect of 20-HETE mimetic, 5,14-HEDGE, on NLRP3/ASC/pro-caspase-1 inflammasome formation and activity in lipopolysaccharide-induced septic shock model in rats, BAP, Project Number: 2015-AP3-1343, 20000 TL, Researcher, 2017,Completed. 50

20. Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, BAP, Project Number: 2016-1-TP2-1427, 11000 TL, Researcher, 2016,Completed. 50

19. Lipopolisakkarit ile farelerde oluşturulan inflamatuvar hiperaljeziye NLRP3 inflamazomunun katkısının araştırılması., TÜBİTAK, Project Number: 215S047, 30000 TL, Researcher, 2016,Completed. 50

18. Periferik iskemi/reperfüzyona bağlı hedef ve uzak organ zedelenmesinde Rho-kinaz etkinliğindeki değişimlerin mekanizmasının araştırılması. , BAP, Project Number: 2015-TP2-1191, 7000 TL, Researcher, 2016,Completed. 50

17. Investigation of the effect of 20-HETE agonist, 5,14-HEDGE, on PPAR/β/, c-jun, importin-3 ve RXR expression in renal and cardiovascular tissues of endotoxemic rats. , BAP, Project Number: BAP-SBE FB (ŞPŞ) 2014-3 YL, 10000 TL, Researcher, 2015,Completed. 50

16. Investigation of the effect of 20-HETE agonist, 5,14-HEDGE, on systemic miR-150, miR-223, and miR-297 levels in relation with activity of MyD88/TAK1/NF-B pathway in endotoxemic rats. , BAP, Project Number: BAP-SBE EMBB (ANS) 2012-4 DR, 20000 TL, Researcher, 2013,Completed. 50

15. Investigation of the effect of a 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity in relation with proinflammatory cytokine production and MEK1/ERK1/2/NF-B pathway in endotoxemic., BAP, Project Number: BAP-ECZ F FB (BT) 2010-5 B, 42000 TL, Researcher, 2012,Completed. 50

14. Investigation of molecular mechanism of the interaction between nitric oxide synthase, cyclooxygenase and cytochrome P450 4A enzymes in cardiac, renal and vascular tissues of endotoxemic rats. , TÜBİTAK, Project Number: 109S121, 0 TL, Researcher, 2012,Completed. 50

13. Investigation of the contribution of spleen tyrosine kinase to endotoxin-induced hypotension in rats. , BAP, Project Number: BAP SBE F (MK) 2011-5 YL, 1000 TL, Researcher, 2012,Completed. 50

12. Investigation of the relationship between IL-6, IL-8 and TNF-alpha gene polymorphism and myocardial injury during cardiopulmonary bypass in patients under ACE inhibitor therapy. , BAP, Project Number: BAP-TF CTB (NS) 2009-3, 17005 TL, Researcher, 2012,Completed. 50

11. Increased NO production and decreased levels of 20-HETE accompanied with hypotension via contribution of COX-2 products in endotoxemic rats. , Novartis Sağlık, Gıda ve Tarım Ürünleri Sanayi ve Ticaret A.Ş., Project Number: Novartis, 13000 TL, Researcher, 2012,Completed. 0

10. Investigation of the relationship between ACE gene polymorphism and effect of ACE inhibition on myocardial injury during cardiopulmonary bypass. , BAP, Project Number: BAP-TF CTB (NS) 2009-3, 4000 TL, Researcher, 2011,Completed. 50

9. Investigation of the mechanism of preventive effect of selective 20-HETE agonist N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine on endotoxin-induced hypotension. , BAP, Project Number: BAP SBE EMB (TC) 2008-6 DR, 0 TL, Researcher, 2010,Completed. 50

8. The Role of CYP1B1 in developement and Maintenance of Hypertension in Rats., TÜBİTAK, Project Number: 2219, 0 TL, Researcher, 2010,Completed. 50

7. Effect of selective Rho-kinase inhibitor, Y-27632, on ischemia/reperfusion-induced target-organ skeletal muscle and end-organ kidney damage. , BAP, Project Number: BAP SBE EMB (ANS) 2008-9 YL, 7847 TL, Researcher, 2009,Completed. 50

6. Mechanism of apoptosis in hepatocellular carcinoma and effect of some benzimidazole derivatives on hepatocellular carcinoma. , BAP, Project Number: BAP-SBE BA (AG) 2008-9 YL , 5969 TL, Researcher, 2009,Completed. 50

5. Investigation of selective 20-HETE agonist mechanism, N-[20-hydroxieicoza-5(Z),14(Z)-dienoil]glycine which prevents hypotension and vascular hyporeactivity mediated by nitric oxide via hypotension induced with endotoxin. , Novartis Sağlık, Gıda ve Tarım Ürünleri Sanayi ve Ticaret A.Ş., Project Number: Novartis , 10000 TL, Researcher, 2009,Completed. 0

4. Investigation of the mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 and inducible nitric oxide pathway in endotoxemic rats. , TÜBİTAK, Project Number: 106S299 (SBAG-3508), 105360 TL, Researcher, 2009,Completed. 50

3. Investigation of the mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 pathway in endotoxemic rats. Mersin University Research Foundation, Project no: BAP SBE EMB (RBK) 2006-3 DR, BAP, Project Number: BAP SBE EMB (RBK) 2006-3 DR, 6000 TL, Researcher, 2008,Completed. 50

2. Investigation of the effects of thalidomide in endotoxin-induced hyperalgesia. , BAP, Project Number: BAP SBE EMB (OÖ) 2006-3 YL, 6000 TL, Researcher, 2008,Completed. 50

1. Contribution of cytochrom P450 and cyclooxygenase products endotoxin-induced and nitric oxide-mediated hypotension. , BAP, Project Number: BAP ECZF EMB (BT) 2006-3, 10000 TL, Researcher, 2008,Completed. 50

Supervised Master Theses 1000

5. Çağla AKINCI UYSAL, Sıçanlarda Periferik İskemi/Reperfüzyon Zedelenmesine Aracılık Eden İnflamatuvar Yanıt ve Oksidatif/Nitrozatif Stres Süreçlerinde mTOR'un katkısının MEK1/ERK1/2 Etkinliği ile İlişkilendirilerek Araştırılması, Graduate School of Health Sciences, Mersin University, Continue. 200

4. Demet ÜNSAL, Investigation of the Contribution of Spleen Tyrosine Kinase on Zymosan-Induced Hypotension in Rats, Graduate School of Health Sciences, Mersin University, Completed. 200

3. Meryem TEMİZ, Investigation of Contribution of mTOR in LPS-Induced Hypotension and Inflammation in Rats, Graduate School of Health Sciences, Mersin University, Completed. 200

2. Zarife PİRE, Investigation of the Contribution of mTOR to Peripheral Ischemia/Reperfusion Injury Associated with Apoptosis in Rats, Graduate School of Health Sciences, Mersin University, Continue. 200

1. Zümrüt KOÇAK , Sıçanlarda İskemi/Reperfüzyona Bağlı Ortaya Çıkan Hedef ve Uzak Organ Zedelenmelerinde Oluşan İnflamasyon İle Oksidatif/Nitrozatif Strese mTOR’un Katkısının Araştırılması. , Graduate School of Health Sciences, Mersin University, 2016, Completed. 200

Supervised Doctorate Theses 800

2. Meryem Temiz Reşitoğlu, Investigation Of The Contribution Of Mtor To DOCA-Salt İnduced Hypertension And Associated Cardiovascular And Renal Pathophysiological Changes İn Rats, Graduate School of Health Sciences, Mersin University, Continue. 400

1. Demet Sinem GÜDEN, Investigation of the role of mTOR in lipopolysaccaride-induced systemic inflammatory response associated with neuroinflammation in rats , Graduate School of Health Sciences, Mersin University, Continue. 400

International Journal [Year, Count] 54
1. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , [ 2018 : 1 ] . 5
2. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , [ 2018 : 1 ] . 5
3. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , [ 2018 : 1 ] . 5
4. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , [ 2018 : 1 ] [ 0 : 0 ] . 5
5. MOLECULAR AND CLINICAL ONCOLOGY , [ 2018 : 1 ] . 4
6. ONCOLOGY LETTERS , [ 2018 : 1 ] . 5
7. ONCOLOGY LETTERS , [ 2018 : 1 ] . 5
8. ONCOLOGY LETTERS , [ 2017 : 1 ] . 5
9. ONCOLOGY REPORTS , [ 2018 : 1 ] . 5
10. PHARMACOLOGY , [ 2017 : 1 ] . 5
11. TURKISH JOURNAL OF BIOLOGY , [ 2015 : 1 ] . 5
National Journal [Year, Count] 9
1. CUKUROVA MEDICAL JOURNAL (CUKUROVA UNIVERSITESI TIP FAKULTESI DERGISI) , [ 2017 : 1 ] . 1
2. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , [ 2017 : 1 ] . 1
3. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , [ 2016 : 1 ] . 1
4. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , [ 2016 : 1 ] . 1
5. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , [ 2017 : 1 ] . 1
6. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , [ 2018 : 1 ] . 1
7. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , [ 2018 : 1 ] . 1
8. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , [ 2018 : 1 ] . 1
9. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , [ 2018 : 1 ] . 1
International 100
1. 1th Central and Eastern European Sepsis Forum SepsEast, 2012-09-19, Budapeşte, Hungary. 50
2. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, Amsterdam, Netherlands. 50
National 125
1. Novartis Health, Food and Agriculture Products Industry and Trade Corporation, 2008-04-14, Ankara, Turkey. 50
2. , 2009-04-14, Ankara, Turkey. 50
3. XXIII. International Biochemistry Congress, 2011-05-29, Adana, Turkey. 25
3. Turkish Society of Pharmacology , Member No: Üye No: 742, Turkey, 2005-06-12-Continue.
2. Veteriner Farmakoloji ve Toksikoloji Derneği , Member No: -, Turkey, 2005-06-01-Continue.
1. Mersin Veteriner Hekimleri Odası , Member No: -, Turkey, 2005-01-01-Continue.
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 1-2-2
Spring FMK 512 Experimental Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Spring FMK 515 Scientific Presentation and Writing Tech... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 503 Drugs Affecting Cardiovascular System Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Spring IDU202 Ilac Disi Urunler Vocational School of Mersin Pharmacy Services ( Distance E... 3-0-3
Fall EFMK507 Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 1-2-2
Fall FMK 626 Pain and Analgesics Institute of Health Sciences Pharmacy Pharmacology 1-0-1
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 512 Experimental Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Fall FMK 623 Inflammation and Antiinflammatory Drugs Institute of Health Sciences Pharmacy Pharmacology 1-0-1
Fall FMK 607 Experimental Pharmacology II Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-3
Spring FMK 604 Experimental Pharmacology I Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Spring FMK 503 Drugs Affecting Cardiovascular System Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Spring FMK 515 Scientific Presentation and Writing Tech... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 2-6-5
Fall FMK 515 Scientific Presentation and Writing Tech... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Fall FMK 505 Autocoids Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 516 Methods For Preparing Project Proposal Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 503 Drugs Affecting Cardiovascular System Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-2
Spring FMK 503 Drugs Affecting Cardiovascular System Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Spring FMK 516 Methods For Preparing Project Proposal Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FZY102 Fizyoloji Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 2-6-4
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 515 Scientific Presentation and Writing Tech... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 604 Experimental Pharmacology I Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Fall SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Fall FMK 618 Postgraduate Education In Pharmacology Institute of Health Sciences Pharmacy Pharmacology 1-0-1
Fall FMK 611 Scientific Presentation and Writing Meth... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall TTB101 Tibbi Terim Bilgisi Vocational School of Mersin Health Institutions Management... 3-0-3
Fall TTB101 Tibbi Terim Bilgisi Vocational School of Mersin Pharmacy Services ( Distance E... 3-0-3
Fall TTB101 Medical Term Knowledge Vocational School of Mersin Medical Promotion and Marketin... 3-0-3
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-2
Spring SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 512 Experimental Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Spring FMK 623 Inflammation and Antiinflammatory Drugs Institute of Health Sciences Pharmacy Pharmacology 1-0-1
Spring FMK 503 Drugs Affecting Cardiovascular System Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FZY102 Fizyoloji Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Fall FMK 611 Scientific Presentation and Writing Meth... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 607 Experimental Pharmacology II Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Fall FMK 618 Postgraduate Education In Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 1-0-1
Fall FMK 515 Scientific Presentation and Writing Tech... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall TTB101 Medical Term Knowledge Vocational School of Mersin Medical Promotion and Marketin... 3-0-3
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring FMK 603 Mechanisms For Searching and Evaluation ... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FMK 604 Experimental Pharmacology I Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Spring FMK 608 Pharmacokinetics Graduate School of Health Scie... PHARMACY PHARMACOLOGY 3-0-3
Spring FZY102 Fizyoloji Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Fall FMK 607 Experimental Pharmacology II Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Fall FMK 503 Drugs Affecting Cardiovascular System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-2-3
Fall TTB101 Tibbi Terim Bilgisi Vocational School of Mersin Health Institutions Management... 3-0-3
Fall TTB101 Tibbi Terim Bilgisi Vocational School of Mersin Pharmacy Services ( Distance E... 3-0-3
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring FMK 503 Drugs Affecting Cardiovascular System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-2-3
Spring FMK 505 Autocoids Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FMK 515 Scientific Presentation and Writing Tech... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FMK 520 Seminar Graduate School of Health Scie... PHARMACY PHARMACOLOGY 0-0-0
Spring FMK 609 Biostatistics and Computer Applications ... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FZY102 Fizyoloji Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Spring FZY102 Physiology Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Fall FMK 505 Autocoids Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 502 Drugs Affecting Autonomic Nervous System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 506 Drugs Affecting Endocrine System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 503 Drugs Affecting Cardiovascular System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-2-3
Fall TTB101 Medical Term Knowledge Vocational School of Mersin Cosmetics Technology ( Distanc... 3-0-3
Fall TTB101 Medical Term Knowledge Vocational School of Mersin Medical Promotion and Marketin... 3-0-3
Fall TTB101 Tibbi Terim Bilgisi Vocational School of Mersin Health Institutions Management... 3-0-3
Fall TTB101 Tibbi Terim Bilgisi Vocational School of Mersin Pharmacy Services ( Distance E... 3-0-3
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring FMK 505 Autocoids Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring KTP110 Vocational School of Mersin Cosmetics Technology ( Distanc... 2-0-2
Spring TTP102 Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Spring EHP104 Phsiology Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring SKİP262* Vocational School of Mersin Health Institutions Management... 2-0-2
Spring EHP102 Anatomy Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Spring SKİP250 Vocational School of Mersin Health Institutions Management... 3-0-3
Spring TTP102 Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Spring EHP104 Phsiology Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Fall FMK 628 Pharmacogenomics Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall TTP237 Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Fall TTP107 Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Fall TTP239 Customer Relations Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring TTP102 Vocational School of Mersin Medical Promotion and Marketin... 2-0-2
Spring EHP104 Phsiology Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Spring EHP102 Anatomy Vocational School of Mersin Pharmacy Services ( Distance E... 2-0-2
Fall TTP107 Vocational School of Mersin Medical Promotion and Marketin... 2-0-2